George Eric Davis - Apr 29, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Legal Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Apr 29, 2022
Transactions value $
-$637,412
Form type
4
Date filed
5/4/2022, 12:01 PM
Previous filing
Apr 27, 2022
Next filing
Jul 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $21.3K +341 +0.52% $62.41 66.3K Apr 29, 2022 Direct F1
transaction BMRN Common Stock Options Exercise $575K +15.3K +23.13% $37.46 81.7K May 2, 2022 Direct F2
transaction BMRN Common Stock Sale -$1.23M -15.3K -18.79% $80.38 66.3K May 2, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -15.3K -100% $0.00* 0 May 2, 2022 Common Stock 15.3K $37.46 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by the reporting person on April 29, 2022, pursuant to the issuer's Employee Stock Purchase Plan.
F2 Trade made pursuant to a 10b5-1 plan executed on March 4, 2022.
F3 Reflects the number of options outstanding after the transactions from this specific stock option grant.